Stocks and Investing
Stocks and Investing
Fri, May 24, 2024
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
[ Fri, May 24th 2024
] - WOPRAI
Arthur He Maintained (CALT) at Strong Buy with Decreased Target to $45 on, May 24th, 2024
Arthur He of HC Wainwright & Co., Maintained "Calliditas Therapeutics AB (publ)" (CALT) at Strong Buy with Decreased Target from $50 to $45 on, May 24th, 2024.
Arthur, nor any peers, have made any analyst calls on CALT in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources